'lenvatinib'
(id=5830899 ; fe=lenvatinib ; type=777 ; niveau=200 ; luminosité=25 ; somme entrante=9367 creation date=2017-05-27 touchdate=2025-07-24 23:55:57.000)

≈ 482 relations sortantes lenvatinib -- r_associated #0: 94 / 1 -> en:alk inhibitor ro5424802 n1=lenvatinib | n2=en:alk inhibitor ro5424802 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:apatinib n1=lenvatinib | n2=en:apatinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:brivanib alaninate n1=lenvatinib | n2=en:brivanib alaninate | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:c-met inhibitor msc2156119j n1=lenvatinib | n2=en:c-met inhibitor msc2156119j | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:capmatinib n1=lenvatinib | n2=en:capmatinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:ceritinib n1=lenvatinib | n2=en:ceritinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:cobimetinib n1=lenvatinib | n2=en:cobimetinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:dasatinib anhydrous n1=lenvatinib | n2=en:dasatinib anhydrous | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:dovitinib lactate anhydrous n1=lenvatinib | n2=en:dovitinib lactate anhydrous | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:egfr/her2 inhibitor ap32788 n1=lenvatinib | n2=en:egfr/her2 inhibitor ap32788 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:fgfr inhibitor tas-120 n1=lenvatinib | n2=en:fgfr inhibitor tas-120 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:flosequinan n1=lenvatinib | n2=en:flosequinan | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:fostamatinib n1=lenvatinib | n2=en:fostamatinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:halquinol n1=lenvatinib | n2=en:halquinol | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:igf-1r inhibitor pl225b n1=lenvatinib | n2=en:igf-1r inhibitor pl225b | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:jak1 inhibitor n1=lenvatinib | n2=en:jak1 inhibitor | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:jak1 inhibitor incb052793 n1=lenvatinib | n2=en:jak1 inhibitor incb052793 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:kit/pdgfr inhibitor dcc-2618 n1=lenvatinib | n2=en:kit/pdgfr inhibitor dcc-2618 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:labetalol n1=lenvatinib | n2=en:labetalol | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:lanolin n1=lenvatinib | n2=en:lanolin | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:latex n1=lenvatinib | n2=en:latex | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:latrodectus mactans antivenin n1=lenvatinib | n2=en:latrodectus mactans antivenin | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:lemotussin-dm n1=lenvatinib | n2=en:lemotussin-dm | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:leuprolide/norethindrone n1=lenvatinib | n2=en:leuprolide/norethindrone | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:levocetirizine n1=lenvatinib | n2=en:levocetirizine | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:levodopa n1=lenvatinib | n2=en:levodopa | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:levothyroxine n1=lenvatinib | n2=en:levothyroxine | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:lidocaine / sodium chloride n1=lenvatinib | n2=en:lidocaine / sodium chloride | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:linagliptin n1=lenvatinib | n2=en:linagliptin | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:lindora n1=lenvatinib | n2=en:lindora | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:linoleic acid n1=lenvatinib | n2=en:linoleic acid | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:linsitinib n1=lenvatinib | n2=en:linsitinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:liponoid n1=lenvatinib | n2=en:liponoid | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:loxapine n1=lenvatinib | n2=en:loxapine | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:lypressin n1=lenvatinib | n2=en:lypressin | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:met tyrosine kinase inhibitor pf-04217903 n1=lenvatinib | n2=en:met tyrosine kinase inhibitor pf-04217903 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:momelotinib n1=lenvatinib | n2=en:momelotinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:multikinase inhibitor 4sc-203 n1=lenvatinib | n2=en:multikinase inhibitor 4sc-203 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:pazopanib hydrochloride n1=lenvatinib | n2=en:pazopanib hydrochloride | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:quaternary quinolinium surfactant n1=lenvatinib | n2=en:quaternary quinolinium surfactant | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:quinoline dye n1=lenvatinib | n2=en:quinoline dye | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:quinolone antibacterial agents n1=lenvatinib | n2=en:quinolone antibacterial agents | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:saracatinib n1=lenvatinib | n2=en:saracatinib | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:vegfr/fgfr inhibitor odm-203 n1=lenvatinib | n2=en:vegfr/fgfr inhibitor odm-203 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:vegfr2 tyrosine kinase inhibitor pf-00337210 n1=lenvatinib | n2=en:vegfr2 tyrosine kinase inhibitor pf-00337210 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 94 / 1 -> en:wee1 inhibitor azd1775 n1=lenvatinib | n2=en:wee1 inhibitor azd1775 | rel=r_associated | relid=0 | w=94 lenvatinib -- r_associated #0: 93 / 0.989 -> en:alk inhibitor asp3026 n1=lenvatinib | n2=en:alk inhibitor asp3026 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:aminogenistein n1=lenvatinib | n2=en:aminogenistein | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:bafetinib n1=lenvatinib | n2=en:bafetinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:c-met inhibitor mk2461 n1=lenvatinib | n2=en:c-met inhibitor mk2461 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:cetuximab n1=lenvatinib | n2=en:cetuximab | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:daidzein n1=lenvatinib | n2=en:daidzein | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:dovitinib n1=lenvatinib | n2=en:dovitinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:fak inhibitor pf-00562271 n1=lenvatinib | n2=en:fak inhibitor pf-00562271 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:fak inhibitor vs-4718 n1=lenvatinib | n2=en:fak inhibitor vs-4718 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:fda established names and unique ingredient identifier codes terminology n1=lenvatinib | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:flumatinib mesylate n1=lenvatinib | n2=en:flumatinib mesylate | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:fms/trk tyrosine kinase inhibitor plx7486 tosylate n1=lenvatinib | n2=en:fms/trk tyrosine kinase inhibitor plx7486 tosylate | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:foretinib n1=lenvatinib | n2=en:foretinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:henatinib maleate n1=lenvatinib | n2=en:henatinib maleate | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:ibrutinib n1=lenvatinib | n2=en:ibrutinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:jak inhibitor incb047986 n1=lenvatinib | n2=en:jak inhibitor incb047986 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:jak1 inhibitor incb039110 n1=lenvatinib | n2=en:jak1 inhibitor incb039110 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lactic acid n1=lenvatinib | n2=en:lactic acid | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lactic acid/methyl salicylate/octoxynol 9/sodium bicarbonate n1=lenvatinib | n2=en:lactic acid/methyl salicylate/octoxynol 9/sodium bicarbonate | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lactobacillus n1=lenvatinib | n2=en:lactobacillus | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lanolin/mineral oil/parabens n1=lenvatinib | n2=en:lanolin/mineral oil/parabens | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lemon oil n1=lenvatinib | n2=en:lemon oil | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:leucovorin n1=lenvatinib | n2=en:leucovorin | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:leutein n1=lenvatinib | n2=en:leutein | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:levobupivacaine n1=lenvatinib | n2=en:levobupivacaine | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:levocabastine n1=lenvatinib | n2=en:levocabastine | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:levomethadyl n1=lenvatinib | n2=en:levomethadyl | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lipomuls n1=lenvatinib | n2=en:lipomuls | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:lissamine green n1=lenvatinib | n2=en:lissamine green | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:liver extract n1=lenvatinib | n2=en:liver extract | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:masitinib mesylate n1=lenvatinib | n2=en:masitinib mesylate | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:osimertinib n1=lenvatinib | n2=en:osimertinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:pan fgfr inhibitor prn1371 n1=lenvatinib | n2=en:pan fgfr inhibitor prn1371 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:pazopanib n1=lenvatinib | n2=en:pazopanib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:pdgfr alpha/kit mutant-specific inhibitor blu-285 n1=lenvatinib | n2=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:pexidartinib n1=lenvatinib | n2=en:pexidartinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:picropodophyllin n1=lenvatinib | n2=en:picropodophyllin | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:pirotinib n1=lenvatinib | n2=en:pirotinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:quizartinib n1=lenvatinib | n2=en:quizartinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:quizartinib dihydrochloride n1=lenvatinib | n2=en:quizartinib dihydrochloride | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:su4984 n1=lenvatinib | n2=en:su4984 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:sunitinib n1=lenvatinib | n2=en:sunitinib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:tivozanib n1=lenvatinib | n2=en:tivozanib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:trk inhibitor loxo-101 n1=lenvatinib | n2=en:trk inhibitor loxo-101 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:tyrosine kinase inhibitor su5402 n1=lenvatinib | n2=en:tyrosine kinase inhibitor su5402 | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 93 / 0.989 -> en:vandetanib n1=lenvatinib | n2=en:vandetanib | rel=r_associated | relid=0 | w=93 lenvatinib -- r_associated #0: 92 / 0.979 -> en:c-met inhibitor amg 337 n1=lenvatinib | n2=en:c-met inhibitor amg 337 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:cinchophen n1=lenvatinib | n2=en:cinchophen | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:curcumin n1=lenvatinib | n2=en:curcumin | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:damnacanthal n1=lenvatinib | n2=en:damnacanthal | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:defactinib n1=lenvatinib | n2=en:defactinib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:dodecyl sulfate n1=lenvatinib | n2=en:dodecyl sulfate | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:fgfr inhibitor debio 1347 n1=lenvatinib | n2=en:fgfr inhibitor debio 1347 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:flt3/kit kinase inhibitor akn-028 n1=lenvatinib | n2=en:flt3/kit kinase inhibitor akn-028 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:fostamatinib disodium n1=lenvatinib | n2=en:fostamatinib disodium | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:genistein n1=lenvatinib | n2=en:genistein | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lead acetate n1=lenvatinib | n2=en:lead acetate | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lecithin n1=lenvatinib | n2=en:lecithin | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lenvatinib 10 mg oral capsule n1=lenvatinib | n2=en:lenvatinib 10 mg oral capsule | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lenvatinib mesylate n1=lenvatinib | n2=en:lenvatinib mesylate | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:levofloxacin n1=lenvatinib | n2=en:levofloxacin | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:levoleucovorin n1=lenvatinib | n2=en:levoleucovorin | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:levonordefrin n1=lenvatinib | n2=en:levonordefrin | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:licorice n1=lenvatinib | n2=en:licorice | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lidocaine n1=lenvatinib | n2=en:lidocaine | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lidocaine / menthol / methyl salicylate n1=lenvatinib | n2=en:lidocaine / menthol / methyl salicylate | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:linifanib n1=lenvatinib | n2=en:linifanib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:liothyronine n1=lenvatinib | n2=en:liothyronine | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lixivaptan n1=lenvatinib | n2=en:lixivaptan | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lobelia spicata leaf extract n1=lenvatinib | n2=en:lobelia spicata leaf extract | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:loratadine/pseudoephedrine n1=lenvatinib | n2=en:loratadine/pseudoephedrine | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lorazepam n1=lenvatinib | n2=en:lorazepam | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lurasidone n1=lenvatinib | n2=en:lurasidone | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:lysine n1=lenvatinib | n2=en:lysine | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:met tyrosine kinase inhibitor sar125844 n1=lenvatinib | n2=en:met tyrosine kinase inhibitor sar125844 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:multitargeted tyrosine kinase inhibitor jnj-26483327 n1=lenvatinib | n2=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:neratinib n1=lenvatinib | n2=en:neratinib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:protein kinase inhibitors [moa] n1=lenvatinib | n2=en:protein kinase inhibitors [moa] | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:receptor tyrosine kinase inhibition n1=lenvatinib | n2=en:receptor tyrosine kinase inhibition | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:ruxolitinib phosphate n1=lenvatinib | n2=en:ruxolitinib phosphate | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:ruxolitinib phosphate cream n1=lenvatinib | n2=en:ruxolitinib phosphate cream | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:src kinase inhibitor kx2-391 ointment n1=lenvatinib | n2=en:src kinase inhibitor kx2-391 ointment | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:sulfatinib n1=lenvatinib | n2=en:sulfatinib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:tesevatinib n1=lenvatinib | n2=en:tesevatinib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:vatalanib n1=lenvatinib | n2=en:vatalanib | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 92 / 0.979 -> en:vegfr inhibitor krn951 n1=lenvatinib | n2=en:vegfr inhibitor krn951 | rel=r_associated | relid=0 | w=92 lenvatinib -- r_associated #0: 91 / 0.968 -> en:alk inhibitor x-396 n1=lenvatinib | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:axitinib n1=lenvatinib | n2=en:axitinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:braf/egfr inhibitor bgb-283 n1=lenvatinib | n2=en:braf/egfr inhibitor bgb-283 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:c-met inhibitor al2846 n1=lenvatinib | n2=en:c-met inhibitor al2846 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:c-met inhibitor mk8033 n1=lenvatinib | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:cp-547632 n1=lenvatinib | n2=en:cp-547632 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:crizotinib n1=lenvatinib | n2=en:crizotinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:defactinib hydrochloride n1=lenvatinib | n2=en:defactinib hydrochloride | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:emodin n1=lenvatinib | n2=en:emodin | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:fgfr4 inhibitor blu-554 n1=lenvatinib | n2=en:fgfr4 inhibitor blu-554 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:gefitinib n1=lenvatinib | n2=en:gefitinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:hypoxia-activated prodrug th-4000 n1=lenvatinib | n2=en:hypoxia-activated prodrug th-4000 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:jak2 inhibitor n1=lenvatinib | n2=en:jak2 inhibitor | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lacidipine n1=lenvatinib | n2=en:lacidipine | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lactase n1=lenvatinib | n2=en:lactase | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lactic acid/vitamin e n1=lenvatinib | n2=en:lactic acid/vitamin e | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lanaphilic ointment n1=lenvatinib | n2=en:lanaphilic ointment | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lapatinib n1=lenvatinib | n2=en:lapatinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lauramide dea/sodium lauryl sulfate n1=lenvatinib | n2=en:lauramide dea/sodium lauryl sulfate | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lemon balm n1=lenvatinib | n2=en:lemon balm | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lenvatinib 4 mg oral capsule n1=lenvatinib | n2=en:lenvatinib 4 mg oral capsule | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:liver/stomach n1=lenvatinib | n2=en:liver/stomach | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:lopinavir/ritonavir n1=lenvatinib | n2=en:lopinavir/ritonavir | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:metatinib tromethamine n1=lenvatinib | n2=en:metatinib tromethamine | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:motesanib n1=lenvatinib | n2=en:motesanib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:radotinib n1=lenvatinib | n2=en:radotinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:ruxolitinib n1=lenvatinib | n2=en:ruxolitinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:tivantinib n1=lenvatinib | n2=en:tivantinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:tofacitinib n1=lenvatinib | n2=en:tofacitinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:tropomyosin receptor kinase inhibitor azd7451 n1=lenvatinib | n2=en:tropomyosin receptor kinase inhibitor azd7451 | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 91 / 0.968 -> en:volitinib n1=lenvatinib | n2=en:volitinib | rel=r_associated | relid=0 | w=91 lenvatinib -- r_associated #0: 89 / 0.947 -> en:anlotinib hydrochloride n1=lenvatinib | n2=en:anlotinib hydrochloride | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:anti-fgfr2 antibody-drug conjugate bay1187982 n1=lenvatinib | n2=en:anti-fgfr2 antibody-drug conjugate bay1187982 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:baricitinib n1=lenvatinib | n2=en:baricitinib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:brivanib n1=lenvatinib | n2=en:brivanib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:c-met inhibitor amg 208 n1=lenvatinib | n2=en:c-met inhibitor amg 208 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:calcium hydroxide n1=lenvatinib | n2=en:calcium hydroxide | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:cep-2563 dihydrochloride n1=lenvatinib | n2=en:cep-2563 dihydrochloride | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:cp-724,714 n1=lenvatinib | n2=en:cp-724,714 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:dual igf-1r/insr inhibitor bms-754807 n1=lenvatinib | n2=en:dual igf-1r/insr inhibitor bms-754807 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:egfr/her2 kinase inhibitor tak-285 n1=lenvatinib | n2=en:egfr/her2 kinase inhibitor tak-285 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:entospletinib n1=lenvatinib | n2=en:entospletinib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:entrectinib n1=lenvatinib | n2=en:entrectinib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:fgf/fgfr pathway inhibitor e7090 n1=lenvatinib | n2=en:fgf/fgfr pathway inhibitor e7090 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 n1=lenvatinib | n2=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:gilteritinib n1=lenvatinib | n2=en:gilteritinib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:imatinib mesylate n1=lenvatinib | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lanolin/mineral oil/octoxynol 3 n1=lenvatinib | n2=en:lanolin/mineral oil/octoxynol 3 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lanolin/mineral oil/petrolatum/triethanolamine n1=lenvatinib | n2=en:lanolin/mineral oil/petrolatum/triethanolamine | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:laronidase n1=lenvatinib | n2=en:laronidase | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lavandula angustifolia flower n1=lenvatinib | n2=en:lavandula angustifolia flower | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:leucine n1=lenvatinib | n2=en:leucine | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:leukocytes/nitrite test n1=lenvatinib | n2=en:leukocytes/nitrite test | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lidocaine / povidone-iodine n1=lenvatinib | n2=en:lidocaine / povidone-iodine | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lidocaine/neomycin/polymyxin n1=lenvatinib | n2=en:lidocaine/neomycin/polymyxin | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:linagliptin + metformin n1=lenvatinib | n2=en:linagliptin + metformin | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lipase n1=lenvatinib | n2=en:lipase | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:liver/multivitamins n1=lenvatinib | n2=en:liver/multivitamins | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lorcaserin n1=lenvatinib | n2=en:lorcaserin | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:loteprednol etabonate + tobramycin n1=lenvatinib | n2=en:loteprednol etabonate + tobramycin | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lumefantrine n1=lenvatinib | n2=en:lumefantrine | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lycium n1=lenvatinib | n2=en:lycium | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:lyme disease vaccine n1=lenvatinib | n2=en:lyme disease vaccine | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:multitargeted kinase inhibitor mgcd516 n1=lenvatinib | n2=en:multitargeted kinase inhibitor mgcd516 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:multitargeted tyrosine kinase inhibitor mgcd265 n1=lenvatinib | n2=en:multitargeted tyrosine kinase inhibitor mgcd265 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:radotinib hydrochloride n1=lenvatinib | n2=en:radotinib hydrochloride | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:rebastinib tosylate n1=lenvatinib | n2=en:rebastinib tosylate | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:src kinase inhibitor kx2-391 n1=lenvatinib | n2=en:src kinase inhibitor kx2-391 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:syk inhibitor hmpl-523 n1=lenvatinib | n2=en:syk inhibitor hmpl-523 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:tandutinib n1=lenvatinib | n2=en:tandutinib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:toceranib n1=lenvatinib | n2=en:toceranib | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:tofacitinib citrate n1=lenvatinib | n2=en:tofacitinib citrate | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 89 / 0.947 -> en:tyrosine kinase inhibitor xl228 n1=lenvatinib | n2=en:tyrosine kinase inhibitor xl228 | rel=r_associated | relid=0 | w=89 lenvatinib -- r_associated #0: 88 / 0.936 -> en:amuvatinib hydrochloride n1=lenvatinib | n2=en:amuvatinib hydrochloride | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:anti-fgfr4 monoclonal antibody u3-1784 n1=lenvatinib | n2=en:anti-fgfr4 monoclonal antibody u3-1784 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:avitinib maleate n1=lenvatinib | n2=en:avitinib maleate | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:axl inhibitor bgb324 n1=lenvatinib | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:c-met inhibitor jnj-38877605 n1=lenvatinib | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:chk1 inhibitor gdc-0575 n1=lenvatinib | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:fgfr inhibitor asp5878 n1=lenvatinib | n2=en:fgfr inhibitor asp5878 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:fgfr inhibitor azd4547 n1=lenvatinib | n2=en:fgfr inhibitor azd4547 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:fgfr4 inhibitor h3b-6527 n1=lenvatinib | n2=en:fgfr4 inhibitor h3b-6527 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:fruquintinib n1=lenvatinib | n2=en:fruquintinib | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:janus kinase inhibitor n1=lenvatinib | n2=en:janus kinase inhibitor | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lactated ringer solution n1=lenvatinib | n2=en:lactated ringer solution | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lagerstroemia preparation n1=lenvatinib | n2=en:lagerstroemia preparation | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lamivudine/zidovudine n1=lenvatinib | n2=en:lamivudine/zidovudine | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lamotrigine n1=lenvatinib | n2=en:lamotrigine | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lanthanum n1=lenvatinib | n2=en:lanthanum | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:leflunomide n1=lenvatinib | n2=en:leflunomide | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lestaurtinib n1=lenvatinib | n2=en:lestaurtinib | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:levalbuterol n1=lenvatinib | n2=en:levalbuterol | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:levetiracetam n1=lenvatinib | n2=en:levetiracetam | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:levomefolate n1=lenvatinib | n2=en:levomefolate | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:levothyroxine sodium+liothyronine sodium n1=lenvatinib | n2=en:levothyroxine sodium+liothyronine sodium | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lindane n1=lenvatinib | n2=en:lindane | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lomefloxacin n1=lenvatinib | n2=en:lomefloxacin | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:loratadine n1=lenvatinib | n2=en:loratadine | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lorenzo's n1=lenvatinib | n2=en:lorenzo's | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lumacaftor n1=lenvatinib | n2=en:lumacaftor | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:lycopene n1=lenvatinib | n2=en:lycopene | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:masitinib n1=lenvatinib | n2=en:masitinib | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:merestinib n1=lenvatinib | n2=en:merestinib | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:panitumumab n1=lenvatinib | n2=en:panitumumab | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:puffball n1=lenvatinib | n2=en:puffball | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:quinfamide n1=lenvatinib | n2=en:quinfamide | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:quinolines n1=lenvatinib | n2=en:quinolines | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:src/tubulin inhibitor kx02 n1=lenvatinib | n2=en:src/tubulin inhibitor kx02 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:st 638 n1=lenvatinib | n2=en:st 638 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:su014813 n1=lenvatinib | n2=en:su014813 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:syk-jak inhibitor prt062070 n1=lenvatinib | n2=en:syk-jak inhibitor prt062070 | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:tectorigenin n1=lenvatinib | n2=en:tectorigenin | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 88 / 0.936 -> en:trametinib n1=lenvatinib | n2=en:trametinib | rel=r_associated | relid=0 | w=88 lenvatinib -- r_associated #0: 87 / 0.926 -> en:{60 (lenvatinib 10 mg oral capsule) } pack [lenvima 20] n1=lenvatinib | n2=en:{60 (lenvatinib 10 mg oral capsule) } pack [lenvima 20] | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:aee788 n1=lenvatinib | n2=en:aee788 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:alk/fak/pyk2 inhibitor ct-707 n1=lenvatinib | n2=en:alk/fak/pyk2 inhibitor ct-707 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:alk/ros1 inhibitor pf-06463922 n1=lenvatinib | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:amuvatinib n1=lenvatinib | n2=en:amuvatinib | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:anti c-kit antibody-drug conjugate lop628 n1=lenvatinib | n2=en:anti c-kit antibody-drug conjugate lop628 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:bruton's tyrosine kinase inhibitor n1=lenvatinib | n2=en:bruton's tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:cediranib n1=lenvatinib | n2=en:cediranib | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:cfms tyrosine kinase inhibitor arry-382 n1=lenvatinib | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:compound 32 n1=lenvatinib | n2=en:compound 32 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:erlotinib n1=lenvatinib | n2=en:erlotinib | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:flt3 inhibitor n1=lenvatinib | n2=en:flt3 inhibitor | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lactic acid bacteria n1=lenvatinib | n2=en:lactic acid bacteria | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lactic acid/octoxynol 9/sodium lactate n1=lenvatinib | n2=en:lactic acid/octoxynol 9/sodium lactate | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lactic acid/phenol/salicylic acid n1=lenvatinib | n2=en:lactic acid/phenol/salicylic acid | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lanolin / mineral oil / petrolatum n1=lenvatinib | n2=en:lanolin / mineral oil / petrolatum | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lavender oil n1=lenvatinib | n2=en:lavender oil | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lavendustin a n1=lenvatinib | n2=en:lavendustin a | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lenvatinib 10 mg daily dose 30 day supply pack n1=lenvatinib | n2=en:lenvatinib 10 mg daily dose 30 day supply pack | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:levamisole n1=lenvatinib | n2=en:levamisole | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:levonordefrin / mepivacaine n1=lenvatinib | n2=en:levonordefrin / mepivacaine | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lincomycin n1=lenvatinib | n2=en:lincomycin | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:linseed oil n1=lenvatinib | n2=en:linseed oil | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:lubiprostone n1=lenvatinib | n2=en:lubiprostone | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:met tyrosine kinase inhibitor bms-777607 n1=lenvatinib | n2=en:met tyrosine kinase inhibitor bms-777607 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:met tyrosine kinase inhibitor sgx523 n1=lenvatinib | n2=en:met tyrosine kinase inhibitor sgx523 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:motesanib diphosphate n1=lenvatinib | n2=en:motesanib diphosphate | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:nilotinib hydrochloride monohydrate n1=lenvatinib | n2=en:nilotinib hydrochloride monohydrate | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 n1=lenvatinib | n2=en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:piceatannol n1=lenvatinib | n2=en:piceatannol | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:pyrotinib n1=lenvatinib | n2=en:pyrotinib | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:regorafenib n1=lenvatinib | n2=en:regorafenib | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:saracatinib difumarate n1=lenvatinib | n2=en:saracatinib difumarate | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:tyrphostin compound n1=lenvatinib | n2=en:tyrphostin compound | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 87 / 0.926 -> en:vegfr tyrosine kinase inhibitor n1=lenvatinib | n2=en:vegfr tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=87 lenvatinib -- r_associated #0: 86 / 0.915 -> en:altiratinib n1=lenvatinib | n2=en:altiratinib | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:btk inhibitor n1=lenvatinib | n2=en:btk inhibitor | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:c-kit inhibitor plx9486 n1=lenvatinib | n2=en:c-kit inhibitor plx9486 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:crenolanib besylate n1=lenvatinib | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:e-7080 n1=lenvatinib | n2=en:e-7080 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:epidermal growth factor receptor tyrosine kinase inhibitor n1=lenvatinib | n2=en:epidermal growth factor receptor tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:fms inhibitor jnj-40346527 n1=lenvatinib | n2=en:fms inhibitor jnj-40346527 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:fostamatinib disodium anhydrous n1=lenvatinib | n2=en:fostamatinib disodium anhydrous | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:gandotinib n1=lenvatinib | n2=en:gandotinib | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:gilteritinib fumarate n1=lenvatinib | n2=en:gilteritinib fumarate | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lactose/milk/minerals/multivitamins/soy oil/sucrose n1=lenvatinib | n2=en:lactose/milk/minerals/multivitamins/soy oil/sucrose | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lancet n1=lenvatinib | n2=en:lancet | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lanolin/mineral oil/oxybenzone n1=lenvatinib | n2=en:lanolin/mineral oil/oxybenzone | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:laureth-23 n1=lenvatinib | n2=en:laureth-23 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:ledipasvir n1=lenvatinib | n2=en:ledipasvir | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:ledipasvir, sofosbuvir drug combination n1=lenvatinib | n2=en:ledipasvir, sofosbuvir drug combination | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lenvatinib 20 mg (as lenvatinib mesylate) daily dose 30 day supply pack n1=lenvatinib | n2=en:lenvatinib 20 mg (as lenvatinib mesylate) daily dose 30 day supply pack | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:levobunolol n1=lenvatinib | n2=en:levobunolol | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:levomilnacipran n1=lenvatinib | n2=en:levomilnacipran | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:linezolid n1=lenvatinib | n2=en:linezolid | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lonalac n1=lenvatinib | n2=en:lonalac | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:loracarbef n1=lenvatinib | n2=en:loracarbef | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:lubricant n1=lenvatinib | n2=en:lubricant | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:met tyrosine kinase inhibitor emd 1204831 n1=lenvatinib | n2=en:met tyrosine kinase inhibitor emd 1204831 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:neocinchophen n1=lenvatinib | n2=en:neocinchophen | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:niacin+lovastatin n1=lenvatinib | n2=en:niacin+lovastatin | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:ntrk/ros1 inhibitor ds-6051b n1=lenvatinib | n2=en:ntrk/ros1 inhibitor ds-6051b | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:pan fgfr kinase inhibitor bgj398 n1=lenvatinib | n2=en:pan fgfr kinase inhibitor bgj398 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 n1=lenvatinib | n2=en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:ponatinib n1=lenvatinib | n2=en:ponatinib | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:receptor tyrosine kinase inhibitor r1530 n1=lenvatinib | n2=en:receptor tyrosine kinase inhibitor r1530 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:sunitinib malate n1=lenvatinib | n2=en:sunitinib malate | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:tepotinib n1=lenvatinib | n2=en:tepotinib | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:vatalanib succinate n1=lenvatinib | n2=en:vatalanib succinate | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:vegfr/pdgfr dual kinase inhibitor x-82 n1=lenvatinib | n2=en:vegfr/pdgfr dual kinase inhibitor x-82 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 n1=lenvatinib | n2=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 86 / 0.915 -> en:xl820 n1=lenvatinib | n2=en:xl820 | rel=r_associated | relid=0 | w=86 lenvatinib -- r_associated #0: 85 / 0.904 -> en:alk-fak inhibitor cep-37440 n1=lenvatinib | n2=en:alk-fak inhibitor cep-37440 | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:aminoquinoline antimalarial (product) n1=lenvatinib | n2=en:aminoquinoline antimalarial (product) | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:brigatinib n1=lenvatinib | n2=en:brigatinib | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:cabozantinib s-malate n1=lenvatinib | n2=en:cabozantinib s-malate | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:crenolanib n1=lenvatinib | n2=en:crenolanib | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:ctrp agent terminology n1=lenvatinib | n2=en:ctrp agent terminology | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:lactate n1=lenvatinib | n2=en:lactate | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:lactose n1=lenvatinib | n2=en:lactose | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:laureth-4 n1=lenvatinib | n2=en:laureth-4 | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:lithium carbonate / sodium chloride n1=lenvatinib | n2=en:lithium carbonate / sodium chloride | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:lotion dosage form n1=lenvatinib | n2=en:lotion dosage form | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:lurasidone hydrochloride n1=lenvatinib | n2=en:lurasidone hydrochloride | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:mutant-selective egfr inhibitor pf-06459988 n1=lenvatinib | n2=en:mutant-selective egfr inhibitor pf-06459988 | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:phenylurea compounds n1=lenvatinib | n2=en:phenylurea compounds | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 85 / 0.904 -> en:sorafenib n1=lenvatinib | n2=en:sorafenib | rel=r_associated | relid=0 | w=85 lenvatinib -- r_associated #0: 80 / 0.851 -> en:alk/trk inhibitor tsr-011 n1=lenvatinib | n2=en:alk/trk inhibitor tsr-011 | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001 n1=lenvatinib | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:cabozantinib n1=lenvatinib | n2=en:cabozantinib | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:ethoxyquin n1=lenvatinib | n2=en:ethoxyquin | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:falnidamol n1=lenvatinib | n2=en:falnidamol | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lanolin / mineral oil n1=lenvatinib | n2=en:lanolin / mineral oil | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lanolin / petrolatum n1=lenvatinib | n2=en:lanolin / petrolatum | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lanolin free n1=lenvatinib | n2=en:lanolin free | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lansoprazole + naproxen n1=lenvatinib | n2=en:lansoprazole + naproxen | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lavendustin c n1=lenvatinib | n2=en:lavendustin c | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:leukocytes test n1=lenvatinib | n2=en:leukocytes test | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lid wipes n1=lenvatinib | n2=en:lid wipes | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lidocaine + tetracaine n1=lenvatinib | n2=en:lidocaine + tetracaine | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lipisorb n1=lenvatinib | n2=en:lipisorb | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lofexidine n1=lenvatinib | n2=en:lofexidine | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:lutein n1=lenvatinib | n2=en:lutein | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:nilotinib n1=lenvatinib | n2=en:nilotinib | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:nintedanib n1=lenvatinib | n2=en:nintedanib | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:octadecatrienoic acid n1=lenvatinib | n2=en:octadecatrienoic acid | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:ornithine, (l)-isomer n1=lenvatinib | n2=en:ornithine, (l)-isomer | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:spleen tyrosine kinase inhibitor tak-659 n1=lenvatinib | n2=en:spleen tyrosine kinase inhibitor tak-659 | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:toceranib phosphate n1=lenvatinib | n2=en:toceranib phosphate | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 80 / 0.851 -> en:vaginal lubricant n1=lenvatinib | n2=en:vaginal lubricant | rel=r_associated | relid=0 | w=80 lenvatinib -- r_associated #0: 35 / 0.372 -> en:angiogenesis inhibitor ji-101 n1=lenvatinib | n2=en:angiogenesis inhibitor ji-101 | rel=r_associated | relid=0 | w=35 lenvatinib -- r_associated #0: 35 / 0.372 -> en:butein n1=lenvatinib | n2=en:butein | rel=r_associated | relid=0 | w=35 lenvatinib -- r_associated #0: 35 / 0.372 -> en:l-methylfolate/methylcobalamin/pyridoxal n1=lenvatinib | n2=en:l-methylfolate/methylcobalamin/pyridoxal | rel=r_associated | relid=0 | w=35 lenvatinib -- r_associated #0: 35 / 0.372 -> en:lansoprazole n1=lenvatinib | n2=en:lansoprazole | rel=r_associated | relid=0 | w=35 lenvatinib -- r_associated #0: 35 / 0.372 -> en:nilotinib hydrochloride anhydrous n1=lenvatinib | n2=en:nilotinib hydrochloride anhydrous | rel=r_associated | relid=0 | w=35 lenvatinib -- r_associated #0: 30 / 0.319 -> en:{30 (lenvatinib 10 mg oral capsule) } pack [lenvima 10] n1=lenvatinib | n2=en:{30 (lenvatinib 10 mg oral capsule) } pack [lenvima 10] | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:afatinib n1=lenvatinib | n2=en:afatinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:alectinib n1=lenvatinib | n2=en:alectinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:axl inhibitor tp-0903 n1=lenvatinib | n2=en:axl inhibitor tp-0903 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:bedaquiline n1=lenvatinib | n2=en:bedaquiline | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:bosutinib n1=lenvatinib | n2=en:bosutinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:c-met inhibitor hs-10241 n1=lenvatinib | n2=en:c-met inhibitor hs-10241 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:cediranib maleate n1=lenvatinib | n2=en:cediranib maleate | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:cysteine n1=lenvatinib | n2=en:cysteine | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:dasatinib n1=lenvatinib | n2=en:dasatinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:dequalinium n1=lenvatinib | n2=en:dequalinium | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:dovitinib lactate n1=lenvatinib | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:eutectic mixture of local anesthetics n1=lenvatinib | n2=en:eutectic mixture of local anesthetics | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:fak inhibitor gsk2256098 n1=lenvatinib | n2=en:fak inhibitor gsk2256098 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:famitinib n1=lenvatinib | n2=en:famitinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:fgfr inhibitor incb054828 n1=lenvatinib | n2=en:fgfr inhibitor incb054828 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:fgfr4 inhibitor fgf401 n1=lenvatinib | n2=en:fgfr4 inhibitor fgf401 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:igf-1r/ir inhibitor kw-2450 n1=lenvatinib | n2=en:igf-1r/ir inhibitor kw-2450 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:imatinib n1=lenvatinib | n2=en:imatinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:ivacaftor n1=lenvatinib | n2=en:ivacaftor | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:l [preparations] n1=lenvatinib | n2=en:l [preparations] | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lactic acid + urea n1=lenvatinib | n2=en:lactic acid + urea | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lactic acid, salicylic acid drug combination n1=lenvatinib | n2=en:lactic acid, salicylic acid drug combination | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lauric diethanolamide n1=lenvatinib | n2=en:lauric diethanolamide | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lavendustin b n1=lenvatinib | n2=en:lavendustin b | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lead oxide n1=lenvatinib | n2=en:lead oxide | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lenvatinib 14 mg (as mesylate) daily dose 30 day supply pack n1=lenvatinib | n2=en:lenvatinib 14 mg (as mesylate) daily dose 30 day supply pack | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lidocaine / menthol n1=lenvatinib | n2=en:lidocaine / menthol | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lilium longiflorium n1=lenvatinib | n2=en:lilium longiflorium | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:liner device n1=lenvatinib | n2=en:liner device | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lipoflavonoid n1=lenvatinib | n2=en:lipoflavonoid | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lithium n1=lenvatinib | n2=en:lithium | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:liver/phenobarbital n1=lenvatinib | n2=en:liver/phenobarbital | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:loperamide+simeticone n1=lenvatinib | n2=en:loperamide+simeticone | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lowila n1=lenvatinib | n2=en:lowila | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lucitanib n1=lenvatinib | n2=en:lucitanib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lutropin alfa n1=lenvatinib | n2=en:lutropin alfa | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:lycopodium clavatum preparation n1=lenvatinib | n2=en:lycopodium clavatum preparation | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:mek inhibitor gdc-0623 n1=lenvatinib | n2=en:mek inhibitor gdc-0623 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:methyl 2,5-dihydroxycinnamate n1=lenvatinib | n2=en:methyl 2,5-dihydroxycinnamate | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:ncit antineoplastic agent terminology n1=lenvatinib | n2=en:ncit antineoplastic agent terminology | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:orantinib n1=lenvatinib | n2=en:orantinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:pan fgfr inhibitor arq 087 n1=lenvatinib | n2=en:pan fgfr inhibitor arq 087 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:pan-fgfr tyrosine kinase inhibitor bay1163877 n1=lenvatinib | n2=en:pan-fgfr tyrosine kinase inhibitor bay1163877 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 n1=lenvatinib | n2=en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:pegdinetanib n1=lenvatinib | n2=en:pegdinetanib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:ponatinib hydrochloride n1=lenvatinib | n2=en:ponatinib hydrochloride | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:quinoline yellow n1=lenvatinib | n2=en:quinoline yellow | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:receptor tyrosine kinase inhibitors [moa] n1=lenvatinib | n2=en:receptor tyrosine kinase inhibitors [moa] | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:semaxanib n1=lenvatinib | n2=en:semaxanib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:src/abl kinase inhibitor azd0424 n1=lenvatinib | n2=en:src/abl kinase inhibitor azd0424 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:telatinib n1=lenvatinib | n2=en:telatinib | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:telatinib mesylate n1=lenvatinib | n2=en:telatinib mesylate | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:trk inhibitor azd6918 n1=lenvatinib | n2=en:trk inhibitor azd6918 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:tyrosine kinase inhibitor osi-930 n1=lenvatinib | n2=en:tyrosine kinase inhibitor osi-930 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 30 / 0.319 -> en:vegf inhibitor ptc299 n1=lenvatinib | n2=en:vegf inhibitor ptc299 | rel=r_associated | relid=0 | w=30 lenvatinib -- r_associated #0: 26 / 0.277 -> en:lenvatinib n1=lenvatinib | n2=en:lenvatinib | rel=r_associated | relid=0 | w=26 lenvatinib -- r_associated #0: 10 / 0.106 -> acide lactique n1=lenvatinib | n2=acide lactique | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> Acide lactique n1=lenvatinib | n2=Acide lactique | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> axitinib n1=lenvatinib | n2=axitinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> baricitinib n1=lenvatinib | n2=baricitinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> cediranib n1=lenvatinib | n2=cediranib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> ceritinib n1=lenvatinib | n2=ceritinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> cetuximab n1=lenvatinib | n2=cetuximab | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> curcumine n1=lenvatinib | n2=curcumine | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> dasatinib n1=lenvatinib | n2=dasatinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> dissolvants n1=lenvatinib | n2=dissolvants | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> E100 n1=lenvatinib | n2=E100 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> E100(i) n1=lenvatinib | n2=E100(i) | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> E270 n1=lenvatinib | n2=E270 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:{60 (lenvatinib 4 mg oral capsule [lenvima]) } pack [lenvima 8] n1=lenvatinib | n2=en:{60 (lenvatinib 4 mg oral capsule [lenvima]) } pack [lenvima 8] | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:2-hydroxypropanoic acid n1=lenvatinib | n2=en:2-hydroxypropanoic acid | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:acid of milk n1=lenvatinib | n2=en:acid of milk | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:agerafenib n1=lenvatinib | n2=en:agerafenib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:akt inhibitor n1=lenvatinib | n2=en:akt inhibitor | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:alisertib sodium n1=lenvatinib | n2=en:alisertib sodium | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:binimetinib-containing product n1=lenvatinib | n2=en:binimetinib-containing product | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:bozitinib n1=lenvatinib | n2=en:bozitinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:edralbrutinib n1=lenvatinib | n2=en:edralbrutinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:Erlotinib n1=lenvatinib | n2=en:Erlotinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:laminaria angustata extract n1=lenvatinib | n2=en:laminaria angustata extract | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:lenvatinib 8 mg (as lenvatinib mesylate) daily dose 30 day supply pack n1=lenvatinib | n2=en:lenvatinib 8 mg (as lenvatinib mesylate) daily dose 30 day supply pack | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:levocarnitine tartrate n1=lenvatinib | n2=en:levocarnitine tartrate | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:lorlatinib n1=lenvatinib | n2=en:lorlatinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:lycoperdon utriforme fruiting body extract n1=lenvatinib | n2=en:lycoperdon utriforme fruiting body extract | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:mek inhibitor ci-1040 n1=lenvatinib | n2=en:mek inhibitor ci-1040 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:mtor kinase inhibitor azd8055 n1=lenvatinib | n2=en:mtor kinase inhibitor azd8055 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:mtor kinase inhibitor pp242 n1=lenvatinib | n2=en:mtor kinase inhibitor pp242 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:orelabrutinib n1=lenvatinib | n2=en:orelabrutinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:pan-her kinase inhibitor ac480 n1=lenvatinib | n2=en:pan-her kinase inhibitor ac480 | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:panobinostat lactate n1=lenvatinib | n2=en:panobinostat lactate | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:pegylated anti-gfr antibody fragment n1=lenvatinib | n2=en:pegylated anti-gfr antibody fragment | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:pimasertib n1=lenvatinib | n2=en:pimasertib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:pirtobrutinib n1=lenvatinib | n2=en:pirtobrutinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:poziotinib n1=lenvatinib | n2=en:poziotinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:refametinib n1=lenvatinib | n2=en:refametinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:rucaparib n1=lenvatinib | n2=en:rucaparib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:selumetinib sulfate n1=lenvatinib | n2=en:selumetinib sulfate | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:solvents n1=lenvatinib | n2=en:solvents | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:talmapimod n1=lenvatinib | n2=en:talmapimod | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:tirabrutinib hydrochloride n1=lenvatinib | n2=en:tirabrutinib hydrochloride | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:vecabrutinib n1=lenvatinib | n2=en:vecabrutinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> en:vistusertib n1=lenvatinib | n2=en:vistusertib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> erlotinib n1=lenvatinib | n2=erlotinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> famitinib n1=lenvatinib | n2=famitinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> génistéine n1=lenvatinib | n2=génistéine | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> graisse de machines n1=lenvatinib | n2=graisse de machines | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> ibrutinib n1=lenvatinib | n2=ibrutinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> imatinib n1=lenvatinib | n2=imatinib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> lacidipine n1=lenvatinib | n2=lacidipine | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> lactase n1=lenvatinib | n2=lactase | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> lactobacillus n1=lenvatinib | n2=lactobacillus | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> lévofloxacine n1=lenvatinib | n2=lévofloxacine | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> licorice n1=lenvatinib | n2=licorice | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> lipase n1=lenvatinib | n2=lipase | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> pazopanib n1=lenvatinib | n2=pazopanib | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> solvants n1=lenvatinib | n2=solvants | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 10 / 0.106 -> vesse de loup n1=lenvatinib | n2=vesse de loup | rel=r_associated | relid=0 | w=10 lenvatinib -- r_associated #0: 9 / 0.096 -> molécule inhibitrice n1=lenvatinib | n2=molécule inhibitrice | rel=r_associated | relid=0 | w=9 lenvatinib -- r_associated #0: 6 / 0.064 -> agent antinéoplasique n1=lenvatinib | n2=agent antinéoplasique | rel=r_associated | relid=0 | w=6 lenvatinib -- r_associated #0: 5 / 0.053 -> composant d'un analyte n1=lenvatinib | n2=composant d'un analyte | rel=r_associated | relid=0 | w=5 lenvatinib -- r_associated #0: 5 / 0.053 -> en:antineoplastic agent n1=lenvatinib | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=5

≈ 468 relations entrantes en:lenvatinib --- r_associated #0: 24 --> lenvatinib n1=en:lenvatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=24 en:aee788 --- r_associated #0: 20 --> lenvatinib n1=en:aee788 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:afatinib --- r_associated #0: 20 --> lenvatinib n1=en:afatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alectinib --- r_associated #0: 20 --> lenvatinib n1=en:alectinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk inhibitor asp3026 --- r_associated #0: 20 --> lenvatinib n1=en:alk inhibitor asp3026 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk inhibitor ro5424802 --- r_associated #0: 20 --> lenvatinib n1=en:alk inhibitor ro5424802 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk inhibitor x-396 --- r_associated #0: 20 --> lenvatinib n1=en:alk inhibitor x-396 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk-fak inhibitor cep-37440 --- r_associated #0: 20 --> lenvatinib n1=en:alk-fak inhibitor cep-37440 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk/fak/pyk2 inhibitor ct-707 --- r_associated #0: 20 --> lenvatinib n1=en:alk/fak/pyk2 inhibitor ct-707 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk/ros1 inhibitor pf-06463922 --- r_associated #0: 20 --> lenvatinib n1=en:alk/ros1 inhibitor pf-06463922 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:alk/trk inhibitor tsr-011 --- r_associated #0: 20 --> lenvatinib n1=en:alk/trk inhibitor tsr-011 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:allosteric bcr-abl tyrosine kinase inhibitor abl001 --- r_associated #0: 20 --> lenvatinib n1=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:altiratinib --- r_associated #0: 20 --> lenvatinib n1=en:altiratinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:aminogenistein --- r_associated #0: 20 --> lenvatinib n1=en:aminogenistein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:aminoquinoline antimalarial (product) --- r_associated #0: 20 --> lenvatinib n1=en:aminoquinoline antimalarial (product) | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:amuvatinib --- r_associated #0: 20 --> lenvatinib n1=en:amuvatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:amuvatinib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:amuvatinib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:angiogenesis inhibitor ji-101 --- r_associated #0: 20 --> lenvatinib n1=en:angiogenesis inhibitor ji-101 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:anlotinib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:anlotinib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:anti c-kit antibody-drug conjugate lop628 --- r_associated #0: 20 --> lenvatinib n1=en:anti c-kit antibody-drug conjugate lop628 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:anti-fgfr2 antibody-drug conjugate bay1187982 --- r_associated #0: 20 --> lenvatinib n1=en:anti-fgfr2 antibody-drug conjugate bay1187982 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:anti-fgfr4 monoclonal antibody u3-1784 --- r_associated #0: 20 --> lenvatinib n1=en:anti-fgfr4 monoclonal antibody u3-1784 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:apatinib --- r_associated #0: 20 --> lenvatinib n1=en:apatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:avitinib maleate --- r_associated #0: 20 --> lenvatinib n1=en:avitinib maleate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:axitinib --- r_associated #0: 20 --> lenvatinib n1=en:axitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:axl inhibitor bgb324 --- r_associated #0: 20 --> lenvatinib n1=en:axl inhibitor bgb324 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:axl inhibitor tp-0903 --- r_associated #0: 20 --> lenvatinib n1=en:axl inhibitor tp-0903 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:bafetinib --- r_associated #0: 20 --> lenvatinib n1=en:bafetinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:baricitinib --- r_associated #0: 20 --> lenvatinib n1=en:baricitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:bedaquiline --- r_associated #0: 20 --> lenvatinib n1=en:bedaquiline | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:bosutinib --- r_associated #0: 20 --> lenvatinib n1=en:bosutinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:braf/egfr inhibitor bgb-283 --- r_associated #0: 20 --> lenvatinib n1=en:braf/egfr inhibitor bgb-283 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:brigatinib --- r_associated #0: 20 --> lenvatinib n1=en:brigatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:brivanib --- r_associated #0: 20 --> lenvatinib n1=en:brivanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:brivanib alaninate --- r_associated #0: 20 --> lenvatinib n1=en:brivanib alaninate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:bruton's tyrosine kinase inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:bruton's tyrosine kinase inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:btk inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:btk inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:butein --- r_associated #0: 20 --> lenvatinib n1=en:butein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-kit inhibitor plx9486 --- r_associated #0: 20 --> lenvatinib n1=en:c-kit inhibitor plx9486 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor al2846 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor al2846 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor amg 208 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor amg 208 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor amg 337 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor amg 337 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor hs-10241 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor hs-10241 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor jnj-38877605 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor jnj-38877605 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor mk2461 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor mk2461 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor mk8033 --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor mk8033 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:c-met inhibitor msc2156119j --- r_associated #0: 20 --> lenvatinib n1=en:c-met inhibitor msc2156119j | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cabozantinib --- r_associated #0: 20 --> lenvatinib n1=en:cabozantinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cabozantinib s-malate --- r_associated #0: 20 --> lenvatinib n1=en:cabozantinib s-malate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:calcium hydroxide --- r_associated #0: 20 --> lenvatinib n1=en:calcium hydroxide | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:capmatinib --- r_associated #0: 20 --> lenvatinib n1=en:capmatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cediranib --- r_associated #0: 20 --> lenvatinib n1=en:cediranib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cediranib maleate --- r_associated #0: 20 --> lenvatinib n1=en:cediranib maleate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cep-2563 dihydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:cep-2563 dihydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ceritinib --- r_associated #0: 20 --> lenvatinib n1=en:ceritinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cetuximab --- r_associated #0: 20 --> lenvatinib n1=en:cetuximab | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cfms tyrosine kinase inhibitor arry-382 --- r_associated #0: 20 --> lenvatinib n1=en:cfms tyrosine kinase inhibitor arry-382 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:chk1 inhibitor gdc-0575 --- r_associated #0: 20 --> lenvatinib n1=en:chk1 inhibitor gdc-0575 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cinchophen --- r_associated #0: 20 --> lenvatinib n1=en:cinchophen | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cobimetinib --- r_associated #0: 20 --> lenvatinib n1=en:cobimetinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:compound 32 --- r_associated #0: 20 --> lenvatinib n1=en:compound 32 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cp-547632 --- r_associated #0: 20 --> lenvatinib n1=en:cp-547632 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cp-724,714 --- r_associated #0: 20 --> lenvatinib n1=en:cp-724,714 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:crenolanib --- r_associated #0: 20 --> lenvatinib n1=en:crenolanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:crenolanib besylate --- r_associated #0: 20 --> lenvatinib n1=en:crenolanib besylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:crizotinib --- r_associated #0: 20 --> lenvatinib n1=en:crizotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ctrp agent terminology --- r_associated #0: 20 --> lenvatinib n1=en:ctrp agent terminology | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:curcumin --- r_associated #0: 20 --> lenvatinib n1=en:curcumin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:cysteine --- r_associated #0: 20 --> lenvatinib n1=en:cysteine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:daidzein --- r_associated #0: 20 --> lenvatinib n1=en:daidzein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:damnacanthal --- r_associated #0: 20 --> lenvatinib n1=en:damnacanthal | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dasatinib --- r_associated #0: 20 --> lenvatinib n1=en:dasatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dasatinib anhydrous --- r_associated #0: 20 --> lenvatinib n1=en:dasatinib anhydrous | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:defactinib --- r_associated #0: 20 --> lenvatinib n1=en:defactinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:defactinib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:defactinib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dequalinium --- r_associated #0: 20 --> lenvatinib n1=en:dequalinium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dodecyl sulfate --- r_associated #0: 20 --> lenvatinib n1=en:dodecyl sulfate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dovitinib --- r_associated #0: 20 --> lenvatinib n1=en:dovitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dovitinib lactate --- r_associated #0: 20 --> lenvatinib n1=en:dovitinib lactate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dovitinib lactate anhydrous --- r_associated #0: 20 --> lenvatinib n1=en:dovitinib lactate anhydrous | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:dual igf-1r/insr inhibitor bms-754807 --- r_associated #0: 20 --> lenvatinib n1=en:dual igf-1r/insr inhibitor bms-754807 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:e-7080 --- r_associated #0: 20 --> lenvatinib n1=en:e-7080 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:egfr/her2 inhibitor ap32788 --- r_associated #0: 20 --> lenvatinib n1=en:egfr/her2 inhibitor ap32788 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:egfr/her2 kinase inhibitor tak-285 --- r_associated #0: 20 --> lenvatinib n1=en:egfr/her2 kinase inhibitor tak-285 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:emodin --- r_associated #0: 20 --> lenvatinib n1=en:emodin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:entospletinib --- r_associated #0: 20 --> lenvatinib n1=en:entospletinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:entrectinib --- r_associated #0: 20 --> lenvatinib n1=en:entrectinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:epidermal growth factor receptor tyrosine kinase inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:epidermal growth factor receptor tyrosine kinase inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:erlotinib --- r_associated #0: 20 --> lenvatinib n1=en:erlotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ethoxyquin --- r_associated #0: 20 --> lenvatinib n1=en:ethoxyquin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:eutectic mixture of local anesthetics --- r_associated #0: 20 --> lenvatinib n1=en:eutectic mixture of local anesthetics | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fak inhibitor gsk2256098 --- r_associated #0: 20 --> lenvatinib n1=en:fak inhibitor gsk2256098 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fak inhibitor pf-00562271 --- r_associated #0: 20 --> lenvatinib n1=en:fak inhibitor pf-00562271 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fak inhibitor vs-4718 --- r_associated #0: 20 --> lenvatinib n1=en:fak inhibitor vs-4718 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:falnidamol --- r_associated #0: 20 --> lenvatinib n1=en:falnidamol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:famitinib --- r_associated #0: 20 --> lenvatinib n1=en:famitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 20 --> lenvatinib n1=en:fda established names and unique ingredient identifier codes terminology | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgf/fgfr pathway inhibitor e7090 --- r_associated #0: 20 --> lenvatinib n1=en:fgf/fgfr pathway inhibitor e7090 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr inhibitor asp5878 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr inhibitor asp5878 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr inhibitor azd4547 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr inhibitor azd4547 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr inhibitor debio 1347 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr inhibitor debio 1347 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr inhibitor incb054828 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr inhibitor incb054828 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr inhibitor tas-120 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr inhibitor tas-120 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr4 inhibitor blu-554 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr4 inhibitor blu-554 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr4 inhibitor fgf401 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr4 inhibitor fgf401 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fgfr4 inhibitor h3b-6527 --- r_associated #0: 20 --> lenvatinib n1=en:fgfr4 inhibitor h3b-6527 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:flosequinan --- r_associated #0: 20 --> lenvatinib n1=en:flosequinan | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:flt3 inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:flt3 inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:flt3/kit kinase inhibitor akn-028 --- r_associated #0: 20 --> lenvatinib n1=en:flt3/kit kinase inhibitor akn-028 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:flumatinib mesylate --- r_associated #0: 20 --> lenvatinib n1=en:flumatinib mesylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fms inhibitor jnj-40346527 --- r_associated #0: 20 --> lenvatinib n1=en:fms inhibitor jnj-40346527 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fms/trk tyrosine kinase inhibitor plx7486 tosylate --- r_associated #0: 20 --> lenvatinib n1=en:fms/trk tyrosine kinase inhibitor plx7486 tosylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:foretinib --- r_associated #0: 20 --> lenvatinib n1=en:foretinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fostamatinib --- r_associated #0: 20 --> lenvatinib n1=en:fostamatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fostamatinib disodium --- r_associated #0: 20 --> lenvatinib n1=en:fostamatinib disodium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fostamatinib disodium anhydrous --- r_associated #0: 20 --> lenvatinib n1=en:fostamatinib disodium anhydrous | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:fruquintinib --- r_associated #0: 20 --> lenvatinib n1=en:fruquintinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:gandotinib --- r_associated #0: 20 --> lenvatinib n1=en:gandotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:gefitinib --- r_associated #0: 20 --> lenvatinib n1=en:gefitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:genistein --- r_associated #0: 20 --> lenvatinib n1=en:genistein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:gilteritinib --- r_associated #0: 20 --> lenvatinib n1=en:gilteritinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:gilteritinib fumarate --- r_associated #0: 20 --> lenvatinib n1=en:gilteritinib fumarate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:halquinol --- r_associated #0: 20 --> lenvatinib n1=en:halquinol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:henatinib maleate --- r_associated #0: 20 --> lenvatinib n1=en:henatinib maleate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:hypoxia-activated prodrug th-4000 --- r_associated #0: 20 --> lenvatinib n1=en:hypoxia-activated prodrug th-4000 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ibrutinib --- r_associated #0: 20 --> lenvatinib n1=en:ibrutinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:igf-1r inhibitor pl225b --- r_associated #0: 20 --> lenvatinib n1=en:igf-1r inhibitor pl225b | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:igf-1r/ir inhibitor kw-2450 --- r_associated #0: 20 --> lenvatinib n1=en:igf-1r/ir inhibitor kw-2450 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:imatinib --- r_associated #0: 20 --> lenvatinib n1=en:imatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:imatinib mesylate --- r_associated #0: 20 --> lenvatinib n1=en:imatinib mesylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ivacaftor --- r_associated #0: 20 --> lenvatinib n1=en:ivacaftor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:jak inhibitor incb047986 --- r_associated #0: 20 --> lenvatinib n1=en:jak inhibitor incb047986 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:jak1 inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:jak1 inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:jak1 inhibitor incb039110 --- r_associated #0: 20 --> lenvatinib n1=en:jak1 inhibitor incb039110 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:jak1 inhibitor incb052793 --- r_associated #0: 20 --> lenvatinib n1=en:jak1 inhibitor incb052793 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:jak2 inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:jak2 inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:janus kinase inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:janus kinase inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:kit/pdgfr inhibitor dcc-2618 --- r_associated #0: 20 --> lenvatinib n1=en:kit/pdgfr inhibitor dcc-2618 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:l [preparations] --- r_associated #0: 20 --> lenvatinib n1=en:l [preparations] | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:l-methylfolate/methylcobalamin/pyridoxal --- r_associated #0: 20 --> lenvatinib n1=en:l-methylfolate/methylcobalamin/pyridoxal | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:labetalol --- r_associated #0: 20 --> lenvatinib n1=en:labetalol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lacidipine --- r_associated #0: 20 --> lenvatinib n1=en:lacidipine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactase --- r_associated #0: 20 --> lenvatinib n1=en:lactase | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactate --- r_associated #0: 20 --> lenvatinib n1=en:lactate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactated ringer solution --- r_associated #0: 20 --> lenvatinib n1=en:lactated ringer solution | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid + urea --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid + urea | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid bacteria --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid bacteria | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid, salicylic acid drug combination --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid, salicylic acid drug combination | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid/methyl salicylate/octoxynol 9/sodium bicarbonate --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid/methyl salicylate/octoxynol 9/sodium bicarbonate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid/octoxynol 9/sodium lactate --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid/octoxynol 9/sodium lactate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid/phenol/salicylic acid --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid/phenol/salicylic acid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactic acid/vitamin e --- r_associated #0: 20 --> lenvatinib n1=en:lactic acid/vitamin e | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactobacillus --- r_associated #0: 20 --> lenvatinib n1=en:lactobacillus | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactose --- r_associated #0: 20 --> lenvatinib n1=en:lactose | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lactose/milk/minerals/multivitamins/soy oil/sucrose --- r_associated #0: 20 --> lenvatinib n1=en:lactose/milk/minerals/multivitamins/soy oil/sucrose | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lagerstroemia preparation --- r_associated #0: 20 --> lenvatinib n1=en:lagerstroemia preparation | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lamivudine/zidovudine --- r_associated #0: 20 --> lenvatinib n1=en:lamivudine/zidovudine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lamotrigine --- r_associated #0: 20 --> lenvatinib n1=en:lamotrigine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanaphilic ointment --- r_associated #0: 20 --> lenvatinib n1=en:lanaphilic ointment | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lancet --- r_associated #0: 20 --> lenvatinib n1=en:lancet | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin --- r_associated #0: 20 --> lenvatinib n1=en:lanolin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin / mineral oil --- r_associated #0: 20 --> lenvatinib n1=en:lanolin / mineral oil | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin / mineral oil / petrolatum --- r_associated #0: 20 --> lenvatinib n1=en:lanolin / mineral oil / petrolatum | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin / petrolatum --- r_associated #0: 20 --> lenvatinib n1=en:lanolin / petrolatum | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin free --- r_associated #0: 20 --> lenvatinib n1=en:lanolin free | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin/mineral oil/octoxynol 3 --- r_associated #0: 20 --> lenvatinib n1=en:lanolin/mineral oil/octoxynol 3 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin/mineral oil/oxybenzone --- r_associated #0: 20 --> lenvatinib n1=en:lanolin/mineral oil/oxybenzone | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin/mineral oil/parabens --- r_associated #0: 20 --> lenvatinib n1=en:lanolin/mineral oil/parabens | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanolin/mineral oil/petrolatum/triethanolamine --- r_associated #0: 20 --> lenvatinib n1=en:lanolin/mineral oil/petrolatum/triethanolamine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lansoprazole --- r_associated #0: 20 --> lenvatinib n1=en:lansoprazole | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lansoprazole + naproxen --- r_associated #0: 20 --> lenvatinib n1=en:lansoprazole + naproxen | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lanthanum --- r_associated #0: 20 --> lenvatinib n1=en:lanthanum | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lapatinib --- r_associated #0: 20 --> lenvatinib n1=en:lapatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:laronidase --- r_associated #0: 20 --> lenvatinib n1=en:laronidase | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:latex --- r_associated #0: 20 --> lenvatinib n1=en:latex | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:latrodectus mactans antivenin --- r_associated #0: 20 --> lenvatinib n1=en:latrodectus mactans antivenin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lauramide dea/sodium lauryl sulfate --- r_associated #0: 20 --> lenvatinib n1=en:lauramide dea/sodium lauryl sulfate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:laureth-23 --- r_associated #0: 20 --> lenvatinib n1=en:laureth-23 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:laureth-4 --- r_associated #0: 20 --> lenvatinib n1=en:laureth-4 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lauric diethanolamide --- r_associated #0: 20 --> lenvatinib n1=en:lauric diethanolamide | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lavandula angustifolia flower --- r_associated #0: 20 --> lenvatinib n1=en:lavandula angustifolia flower | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lavender oil --- r_associated #0: 20 --> lenvatinib n1=en:lavender oil | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lavendustin a --- r_associated #0: 20 --> lenvatinib n1=en:lavendustin a | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lavendustin b --- r_associated #0: 20 --> lenvatinib n1=en:lavendustin b | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lavendustin c --- r_associated #0: 20 --> lenvatinib n1=en:lavendustin c | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lead acetate --- r_associated #0: 20 --> lenvatinib n1=en:lead acetate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lead oxide --- r_associated #0: 20 --> lenvatinib n1=en:lead oxide | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lecithin --- r_associated #0: 20 --> lenvatinib n1=en:lecithin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ledipasvir --- r_associated #0: 20 --> lenvatinib n1=en:ledipasvir | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ledipasvir, sofosbuvir drug combination --- r_associated #0: 20 --> lenvatinib n1=en:ledipasvir, sofosbuvir drug combination | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leflunomide --- r_associated #0: 20 --> lenvatinib n1=en:leflunomide | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lemon balm --- r_associated #0: 20 --> lenvatinib n1=en:lemon balm | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lemon oil --- r_associated #0: 20 --> lenvatinib n1=en:lemon oil | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lemotussin-dm --- r_associated #0: 20 --> lenvatinib n1=en:lemotussin-dm | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib 10 mg daily dose 30 day supply pack --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib 10 mg daily dose 30 day supply pack | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib 10 mg oral capsule --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib 10 mg oral capsule | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib 14 mg (as mesylate) daily dose 30 day supply pack --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib 14 mg (as mesylate) daily dose 30 day supply pack | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib 20 mg (as lenvatinib mesylate) daily dose 30 day supply pack --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib 20 mg (as lenvatinib mesylate) daily dose 30 day supply pack | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib 4 mg oral capsule --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib 4 mg oral capsule | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lenvatinib mesylate --- r_associated #0: 20 --> lenvatinib n1=en:lenvatinib mesylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lestaurtinib --- r_associated #0: 20 --> lenvatinib n1=en:lestaurtinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leucine --- r_associated #0: 20 --> lenvatinib n1=en:leucine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leucovorin --- r_associated #0: 20 --> lenvatinib n1=en:leucovorin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leukocytes test --- r_associated #0: 20 --> lenvatinib n1=en:leukocytes test | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leukocytes/nitrite test --- r_associated #0: 20 --> lenvatinib n1=en:leukocytes/nitrite test | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leuprolide/norethindrone --- r_associated #0: 20 --> lenvatinib n1=en:leuprolide/norethindrone | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:leutein --- r_associated #0: 20 --> lenvatinib n1=en:leutein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levalbuterol --- r_associated #0: 20 --> lenvatinib n1=en:levalbuterol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levamisole --- r_associated #0: 20 --> lenvatinib n1=en:levamisole | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levetiracetam --- r_associated #0: 20 --> lenvatinib n1=en:levetiracetam | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levobunolol --- r_associated #0: 20 --> lenvatinib n1=en:levobunolol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levobupivacaine --- r_associated #0: 20 --> lenvatinib n1=en:levobupivacaine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levocabastine --- r_associated #0: 20 --> lenvatinib n1=en:levocabastine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levocetirizine --- r_associated #0: 20 --> lenvatinib n1=en:levocetirizine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levodopa --- r_associated #0: 20 --> lenvatinib n1=en:levodopa | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levofloxacin --- r_associated #0: 20 --> lenvatinib n1=en:levofloxacin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levoleucovorin --- r_associated #0: 20 --> lenvatinib n1=en:levoleucovorin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levomefolate --- r_associated #0: 20 --> lenvatinib n1=en:levomefolate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levomethadyl --- r_associated #0: 20 --> lenvatinib n1=en:levomethadyl | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levomilnacipran --- r_associated #0: 20 --> lenvatinib n1=en:levomilnacipran | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levonordefrin --- r_associated #0: 20 --> lenvatinib n1=en:levonordefrin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levonordefrin / mepivacaine --- r_associated #0: 20 --> lenvatinib n1=en:levonordefrin / mepivacaine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levothyroxine --- r_associated #0: 20 --> lenvatinib n1=en:levothyroxine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:levothyroxine sodium+liothyronine sodium --- r_associated #0: 20 --> lenvatinib n1=en:levothyroxine sodium+liothyronine sodium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:licorice --- r_associated #0: 20 --> lenvatinib n1=en:licorice | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lid wipes --- r_associated #0: 20 --> lenvatinib n1=en:lid wipes | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine + tetracaine --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine + tetracaine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine / menthol --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine / menthol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine / menthol / methyl salicylate --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine / menthol / methyl salicylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine / povidone-iodine --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine / povidone-iodine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine / sodium chloride --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine / sodium chloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lidocaine/neomycin/polymyxin --- r_associated #0: 20 --> lenvatinib n1=en:lidocaine/neomycin/polymyxin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lilium longiflorium --- r_associated #0: 20 --> lenvatinib n1=en:lilium longiflorium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linagliptin --- r_associated #0: 20 --> lenvatinib n1=en:linagliptin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linagliptin + metformin --- r_associated #0: 20 --> lenvatinib n1=en:linagliptin + metformin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lincomycin --- r_associated #0: 20 --> lenvatinib n1=en:lincomycin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lindane --- r_associated #0: 20 --> lenvatinib n1=en:lindane | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lindora --- r_associated #0: 20 --> lenvatinib n1=en:lindora | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liner device --- r_associated #0: 20 --> lenvatinib n1=en:liner device | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linezolid --- r_associated #0: 20 --> lenvatinib n1=en:linezolid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linifanib --- r_associated #0: 20 --> lenvatinib n1=en:linifanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linoleic acid --- r_associated #0: 20 --> lenvatinib n1=en:linoleic acid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linseed oil --- r_associated #0: 20 --> lenvatinib n1=en:linseed oil | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:linsitinib --- r_associated #0: 20 --> lenvatinib n1=en:linsitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liothyronine --- r_associated #0: 20 --> lenvatinib n1=en:liothyronine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lipase --- r_associated #0: 20 --> lenvatinib n1=en:lipase | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lipisorb --- r_associated #0: 20 --> lenvatinib n1=en:lipisorb | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lipoflavonoid --- r_associated #0: 20 --> lenvatinib n1=en:lipoflavonoid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lipomuls --- r_associated #0: 20 --> lenvatinib n1=en:lipomuls | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liponoid --- r_associated #0: 20 --> lenvatinib n1=en:liponoid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lissamine green --- r_associated #0: 20 --> lenvatinib n1=en:lissamine green | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lithium --- r_associated #0: 20 --> lenvatinib n1=en:lithium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lithium carbonate / sodium chloride --- r_associated #0: 20 --> lenvatinib n1=en:lithium carbonate / sodium chloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liver extract --- r_associated #0: 20 --> lenvatinib n1=en:liver extract | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liver/multivitamins --- r_associated #0: 20 --> lenvatinib n1=en:liver/multivitamins | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liver/phenobarbital --- r_associated #0: 20 --> lenvatinib n1=en:liver/phenobarbital | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:liver/stomach --- r_associated #0: 20 --> lenvatinib n1=en:liver/stomach | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lixivaptan --- r_associated #0: 20 --> lenvatinib n1=en:lixivaptan | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lobelia spicata leaf extract --- r_associated #0: 20 --> lenvatinib n1=en:lobelia spicata leaf extract | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lofexidine --- r_associated #0: 20 --> lenvatinib n1=en:lofexidine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lomefloxacin --- r_associated #0: 20 --> lenvatinib n1=en:lomefloxacin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lonalac --- r_associated #0: 20 --> lenvatinib n1=en:lonalac | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loperamide+simeticone --- r_associated #0: 20 --> lenvatinib n1=en:loperamide+simeticone | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lopinavir/ritonavir --- r_associated #0: 20 --> lenvatinib n1=en:lopinavir/ritonavir | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loracarbef --- r_associated #0: 20 --> lenvatinib n1=en:loracarbef | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loratadine --- r_associated #0: 20 --> lenvatinib n1=en:loratadine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loratadine/pseudoephedrine --- r_associated #0: 20 --> lenvatinib n1=en:loratadine/pseudoephedrine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lorazepam --- r_associated #0: 20 --> lenvatinib n1=en:lorazepam | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lorcaserin --- r_associated #0: 20 --> lenvatinib n1=en:lorcaserin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lorenzo's --- r_associated #0: 20 --> lenvatinib n1=en:lorenzo's | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loteprednol etabonate + tobramycin --- r_associated #0: 20 --> lenvatinib n1=en:loteprednol etabonate + tobramycin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lotion dosage form --- r_associated #0: 20 --> lenvatinib n1=en:lotion dosage form | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lowila --- r_associated #0: 20 --> lenvatinib n1=en:lowila | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:loxapine --- r_associated #0: 20 --> lenvatinib n1=en:loxapine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lubiprostone --- r_associated #0: 20 --> lenvatinib n1=en:lubiprostone | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lubricant --- r_associated #0: 20 --> lenvatinib n1=en:lubricant | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lucitanib --- r_associated #0: 20 --> lenvatinib n1=en:lucitanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lumacaftor --- r_associated #0: 20 --> lenvatinib n1=en:lumacaftor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lumefantrine --- r_associated #0: 20 --> lenvatinib n1=en:lumefantrine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lurasidone --- r_associated #0: 20 --> lenvatinib n1=en:lurasidone | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lurasidone hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:lurasidone hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lutein --- r_associated #0: 20 --> lenvatinib n1=en:lutein | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lutropin alfa --- r_associated #0: 20 --> lenvatinib n1=en:lutropin alfa | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lycium --- r_associated #0: 20 --> lenvatinib n1=en:lycium | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lycopene --- r_associated #0: 20 --> lenvatinib n1=en:lycopene | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lycopodium clavatum preparation --- r_associated #0: 20 --> lenvatinib n1=en:lycopodium clavatum preparation | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lyme disease vaccine --- r_associated #0: 20 --> lenvatinib n1=en:lyme disease vaccine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lypressin --- r_associated #0: 20 --> lenvatinib n1=en:lypressin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:lysine --- r_associated #0: 20 --> lenvatinib n1=en:lysine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:masitinib --- r_associated #0: 20 --> lenvatinib n1=en:masitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:masitinib mesylate --- r_associated #0: 20 --> lenvatinib n1=en:masitinib mesylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:mek inhibitor gdc-0623 --- r_associated #0: 20 --> lenvatinib n1=en:mek inhibitor gdc-0623 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:merestinib --- r_associated #0: 20 --> lenvatinib n1=en:merestinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:met tyrosine kinase inhibitor bms-777607 --- r_associated #0: 20 --> lenvatinib n1=en:met tyrosine kinase inhibitor bms-777607 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:met tyrosine kinase inhibitor emd 1204831 --- r_associated #0: 20 --> lenvatinib n1=en:met tyrosine kinase inhibitor emd 1204831 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:met tyrosine kinase inhibitor pf-04217903 --- r_associated #0: 20 --> lenvatinib n1=en:met tyrosine kinase inhibitor pf-04217903 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:met tyrosine kinase inhibitor sar125844 --- r_associated #0: 20 --> lenvatinib n1=en:met tyrosine kinase inhibitor sar125844 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:met tyrosine kinase inhibitor sgx523 --- r_associated #0: 20 --> lenvatinib n1=en:met tyrosine kinase inhibitor sgx523 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:metatinib tromethamine --- r_associated #0: 20 --> lenvatinib n1=en:metatinib tromethamine | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:methyl 2,5-dihydroxycinnamate --- r_associated #0: 20 --> lenvatinib n1=en:methyl 2,5-dihydroxycinnamate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:momelotinib --- r_associated #0: 20 --> lenvatinib n1=en:momelotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:motesanib --- r_associated #0: 20 --> lenvatinib n1=en:motesanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:motesanib diphosphate --- r_associated #0: 20 --> lenvatinib n1=en:motesanib diphosphate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:multikinase inhibitor 4sc-203 --- r_associated #0: 20 --> lenvatinib n1=en:multikinase inhibitor 4sc-203 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:multitargeted kinase inhibitor mgcd516 --- r_associated #0: 20 --> lenvatinib n1=en:multitargeted kinase inhibitor mgcd516 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:multitargeted tyrosine kinase inhibitor jnj-26483327 --- r_associated #0: 20 --> lenvatinib n1=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:multitargeted tyrosine kinase inhibitor mgcd265 --- r_associated #0: 20 --> lenvatinib n1=en:multitargeted tyrosine kinase inhibitor mgcd265 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:mutant-selective egfr inhibitor pf-06459988 --- r_associated #0: 20 --> lenvatinib n1=en:mutant-selective egfr inhibitor pf-06459988 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ncit antineoplastic agent terminology --- r_associated #0: 20 --> lenvatinib n1=en:ncit antineoplastic agent terminology | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:neocinchophen --- r_associated #0: 20 --> lenvatinib n1=en:neocinchophen | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:neratinib --- r_associated #0: 20 --> lenvatinib n1=en:neratinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:niacin+lovastatin --- r_associated #0: 20 --> lenvatinib n1=en:niacin+lovastatin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:nilotinib --- r_associated #0: 20 --> lenvatinib n1=en:nilotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:nilotinib hydrochloride anhydrous --- r_associated #0: 20 --> lenvatinib n1=en:nilotinib hydrochloride anhydrous | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:nilotinib hydrochloride monohydrate --- r_associated #0: 20 --> lenvatinib n1=en:nilotinib hydrochloride monohydrate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:nintedanib --- r_associated #0: 20 --> lenvatinib n1=en:nintedanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ntrk/ros1 inhibitor ds-6051b --- r_associated #0: 20 --> lenvatinib n1=en:ntrk/ros1 inhibitor ds-6051b | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:octadecatrienoic acid --- r_associated #0: 20 --> lenvatinib n1=en:octadecatrienoic acid | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:orantinib --- r_associated #0: 20 --> lenvatinib n1=en:orantinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ornithine, (l)-isomer --- r_associated #0: 20 --> lenvatinib n1=en:ornithine, (l)-isomer | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:osimertinib --- r_associated #0: 20 --> lenvatinib n1=en:osimertinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan fgfr inhibitor arq 087 --- r_associated #0: 20 --> lenvatinib n1=en:pan fgfr inhibitor arq 087 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan fgfr inhibitor prn1371 --- r_associated #0: 20 --> lenvatinib n1=en:pan fgfr inhibitor prn1371 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan fgfr kinase inhibitor bgj398 --- r_associated #0: 20 --> lenvatinib n1=en:pan fgfr kinase inhibitor bgj398 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 --- r_associated #0: 20 --> lenvatinib n1=en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan-fgfr tyrosine kinase inhibitor bay1163877 --- r_associated #0: 20 --> lenvatinib n1=en:pan-fgfr tyrosine kinase inhibitor bay1163877 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 --- r_associated #0: 20 --> lenvatinib n1=en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 --- r_associated #0: 20 --> lenvatinib n1=en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:panitumumab --- r_associated #0: 20 --> lenvatinib n1=en:panitumumab | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pazopanib --- r_associated #0: 20 --> lenvatinib n1=en:pazopanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pazopanib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:pazopanib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pdgfr alpha/kit mutant-specific inhibitor blu-285 --- r_associated #0: 20 --> lenvatinib n1=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pegdinetanib --- r_associated #0: 20 --> lenvatinib n1=en:pegdinetanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pexidartinib --- r_associated #0: 20 --> lenvatinib n1=en:pexidartinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:phenylurea compounds --- r_associated #0: 20 --> lenvatinib n1=en:phenylurea compounds | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:piceatannol --- r_associated #0: 20 --> lenvatinib n1=en:piceatannol | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:picropodophyllin --- r_associated #0: 20 --> lenvatinib n1=en:picropodophyllin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pirotinib --- r_associated #0: 20 --> lenvatinib n1=en:pirotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ponatinib --- r_associated #0: 20 --> lenvatinib n1=en:ponatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ponatinib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:ponatinib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:protein kinase inhibitors [moa] --- r_associated #0: 20 --> lenvatinib n1=en:protein kinase inhibitors [moa] | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:puffball --- r_associated #0: 20 --> lenvatinib n1=en:puffball | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:pyrotinib --- r_associated #0: 20 --> lenvatinib n1=en:pyrotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quaternary quinolinium surfactant --- r_associated #0: 20 --> lenvatinib n1=en:quaternary quinolinium surfactant | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quinfamide --- r_associated #0: 20 --> lenvatinib n1=en:quinfamide | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quinoline dye --- r_associated #0: 20 --> lenvatinib n1=en:quinoline dye | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quinoline yellow --- r_associated #0: 20 --> lenvatinib n1=en:quinoline yellow | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quinolines --- r_associated #0: 20 --> lenvatinib n1=en:quinolines | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quinolone antibacterial agents --- r_associated #0: 20 --> lenvatinib n1=en:quinolone antibacterial agents | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quizartinib --- r_associated #0: 20 --> lenvatinib n1=en:quizartinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:quizartinib dihydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:quizartinib dihydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:radotinib --- r_associated #0: 20 --> lenvatinib n1=en:radotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:radotinib hydrochloride --- r_associated #0: 20 --> lenvatinib n1=en:radotinib hydrochloride | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:rebastinib tosylate --- r_associated #0: 20 --> lenvatinib n1=en:rebastinib tosylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:receptor tyrosine kinase inhibition --- r_associated #0: 20 --> lenvatinib n1=en:receptor tyrosine kinase inhibition | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:receptor tyrosine kinase inhibitor r1530 --- r_associated #0: 20 --> lenvatinib n1=en:receptor tyrosine kinase inhibitor r1530 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:receptor tyrosine kinase inhibitors [moa] --- r_associated #0: 20 --> lenvatinib n1=en:receptor tyrosine kinase inhibitors [moa] | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:regorafenib --- r_associated #0: 20 --> lenvatinib n1=en:regorafenib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ruxolitinib --- r_associated #0: 20 --> lenvatinib n1=en:ruxolitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ruxolitinib phosphate --- r_associated #0: 20 --> lenvatinib n1=en:ruxolitinib phosphate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:ruxolitinib phosphate cream --- r_associated #0: 20 --> lenvatinib n1=en:ruxolitinib phosphate cream | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:saracatinib --- r_associated #0: 20 --> lenvatinib n1=en:saracatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:saracatinib difumarate --- r_associated #0: 20 --> lenvatinib n1=en:saracatinib difumarate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:semaxanib --- r_associated #0: 20 --> lenvatinib n1=en:semaxanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:sorafenib --- r_associated #0: 20 --> lenvatinib n1=en:sorafenib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:spleen tyrosine kinase inhibitor tak-659 --- r_associated #0: 20 --> lenvatinib n1=en:spleen tyrosine kinase inhibitor tak-659 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:src kinase inhibitor kx2-391 --- r_associated #0: 20 --> lenvatinib n1=en:src kinase inhibitor kx2-391 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:src kinase inhibitor kx2-391 ointment --- r_associated #0: 20 --> lenvatinib n1=en:src kinase inhibitor kx2-391 ointment | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:src/abl kinase inhibitor azd0424 --- r_associated #0: 20 --> lenvatinib n1=en:src/abl kinase inhibitor azd0424 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:src/tubulin inhibitor kx02 --- r_associated #0: 20 --> lenvatinib n1=en:src/tubulin inhibitor kx02 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:st 638 --- r_associated #0: 20 --> lenvatinib n1=en:st 638 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:su014813 --- r_associated #0: 20 --> lenvatinib n1=en:su014813 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:su4984 --- r_associated #0: 20 --> lenvatinib n1=en:su4984 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:sulfatinib --- r_associated #0: 20 --> lenvatinib n1=en:sulfatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:sunitinib --- r_associated #0: 20 --> lenvatinib n1=en:sunitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:sunitinib malate --- r_associated #0: 20 --> lenvatinib n1=en:sunitinib malate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:syk inhibitor hmpl-523 --- r_associated #0: 20 --> lenvatinib n1=en:syk inhibitor hmpl-523 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:syk-jak inhibitor prt062070 --- r_associated #0: 20 --> lenvatinib n1=en:syk-jak inhibitor prt062070 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tandutinib --- r_associated #0: 20 --> lenvatinib n1=en:tandutinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tectorigenin --- r_associated #0: 20 --> lenvatinib n1=en:tectorigenin | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:telatinib --- r_associated #0: 20 --> lenvatinib n1=en:telatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:telatinib mesylate --- r_associated #0: 20 --> lenvatinib n1=en:telatinib mesylate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tepotinib --- r_associated #0: 20 --> lenvatinib n1=en:tepotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tesevatinib --- r_associated #0: 20 --> lenvatinib n1=en:tesevatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tivantinib --- r_associated #0: 20 --> lenvatinib n1=en:tivantinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tivozanib --- r_associated #0: 20 --> lenvatinib n1=en:tivozanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:toceranib --- r_associated #0: 20 --> lenvatinib n1=en:toceranib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:toceranib phosphate --- r_associated #0: 20 --> lenvatinib n1=en:toceranib phosphate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tofacitinib --- r_associated #0: 20 --> lenvatinib n1=en:tofacitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tofacitinib citrate --- r_associated #0: 20 --> lenvatinib n1=en:tofacitinib citrate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:trametinib --- r_associated #0: 20 --> lenvatinib n1=en:trametinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:trk inhibitor azd6918 --- r_associated #0: 20 --> lenvatinib n1=en:trk inhibitor azd6918 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:trk inhibitor loxo-101 --- r_associated #0: 20 --> lenvatinib n1=en:trk inhibitor loxo-101 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tropomyosin receptor kinase inhibitor azd7451 --- r_associated #0: 20 --> lenvatinib n1=en:tropomyosin receptor kinase inhibitor azd7451 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tyrosine kinase inhibitor osi-930 --- r_associated #0: 20 --> lenvatinib n1=en:tyrosine kinase inhibitor osi-930 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tyrosine kinase inhibitor su5402 --- r_associated #0: 20 --> lenvatinib n1=en:tyrosine kinase inhibitor su5402 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tyrosine kinase inhibitor xl228 --- r_associated #0: 20 --> lenvatinib n1=en:tyrosine kinase inhibitor xl228 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:tyrphostin compound --- r_associated #0: 20 --> lenvatinib n1=en:tyrphostin compound | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vaginal lubricant --- r_associated #0: 20 --> lenvatinib n1=en:vaginal lubricant | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vandetanib --- r_associated #0: 20 --> lenvatinib n1=en:vandetanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vatalanib --- r_associated #0: 20 --> lenvatinib n1=en:vatalanib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vatalanib succinate --- r_associated #0: 20 --> lenvatinib n1=en:vatalanib succinate | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegf inhibitor ptc299 --- r_associated #0: 20 --> lenvatinib n1=en:vegf inhibitor ptc299 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr inhibitor krn951 --- r_associated #0: 20 --> lenvatinib n1=en:vegfr inhibitor krn951 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr tyrosine kinase inhibitor --- r_associated #0: 20 --> lenvatinib n1=en:vegfr tyrosine kinase inhibitor | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr/fgfr inhibitor odm-203 --- r_associated #0: 20 --> lenvatinib n1=en:vegfr/fgfr inhibitor odm-203 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr/pdgfr dual kinase inhibitor x-82 --- r_associated #0: 20 --> lenvatinib n1=en:vegfr/pdgfr dual kinase inhibitor x-82 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 --- r_associated #0: 20 --> lenvatinib n1=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:vegfr2 tyrosine kinase inhibitor pf-00337210 --- r_associated #0: 20 --> lenvatinib n1=en:vegfr2 tyrosine kinase inhibitor pf-00337210 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:volitinib --- r_associated #0: 20 --> lenvatinib n1=en:volitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:wee1 inhibitor azd1775 --- r_associated #0: 20 --> lenvatinib n1=en:wee1 inhibitor azd1775 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:xl820 --- r_associated #0: 20 --> lenvatinib n1=en:xl820 | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:{30 (lenvatinib 10 mg oral capsule) } pack [lenvima 10] --- r_associated #0: 20 --> lenvatinib n1=en:{30 (lenvatinib 10 mg oral capsule) } pack [lenvima 10] | n2=lenvatinib | rel=r_associated | relid=0 | w=20 en:{60 (lenvatinib 10 mg oral capsule) } pack [lenvima 20] --- r_associated #0: 20 --> lenvatinib n1=en:{60 (lenvatinib 10 mg oral capsule) } pack [lenvima 20] | n2=lenvatinib | rel=r_associated | relid=0 | w=20 conjugué anticorps-médicament anti-c-kit lop628 --- r_associated #0: 15 --> lenvatinib n1=conjugué anticorps-médicament anti-c-kit lop628 | n2=lenvatinib | rel=r_associated | relid=0 | w=15 E322 --- r_associated #0: 10 --> lenvatinib n1=E322 | n2=lenvatinib | rel=r_associated | relid=0 | w=10 acétate de plomb --- r_associated #0: 10 --> lenvatinib n1=acétate de plomb | n2=lenvatinib | rel=r_associated | relid=0 | w=10 afatinib --- r_associated #0: 10 --> lenvatinib n1=afatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 axitinib --- r_associated #0: 10 --> lenvatinib n1=axitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 baricitinib --- r_associated #0: 10 --> lenvatinib n1=baricitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 ceritinib --- r_associated #0: 10 --> lenvatinib n1=ceritinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 cetuximab --- r_associated #0: 10 --> lenvatinib n1=cetuximab | n2=lenvatinib | rel=r_associated | relid=0 | w=10 curcumine --- r_associated #0: 10 --> lenvatinib n1=curcumine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 cystéine --- r_associated #0: 10 --> lenvatinib n1=cystéine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 dasatinib --- r_associated #0: 10 --> lenvatinib n1=dasatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 erlotinib --- r_associated #0: 10 --> lenvatinib n1=erlotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 ethoxyquine --- r_associated #0: 10 --> lenvatinib n1=ethoxyquine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 hydroxyde de calcium --- r_associated #0: 10 --> lenvatinib n1=hydroxyde de calcium | n2=lenvatinib | rel=r_associated | relid=0 | w=10 ibrutinib --- r_associated #0: 10 --> lenvatinib n1=ibrutinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 imatinib --- r_associated #0: 10 --> lenvatinib n1=imatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 ivacaftor --- r_associated #0: 10 --> lenvatinib n1=ivacaftor | n2=lenvatinib | rel=r_associated | relid=0 | w=10 labetalol --- r_associated #0: 10 --> lenvatinib n1=labetalol | n2=lenvatinib | rel=r_associated | relid=0 | w=10 labétalol --- r_associated #0: 10 --> lenvatinib n1=labétalol | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lacidipine --- r_associated #0: 10 --> lenvatinib n1=lacidipine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lactobacillus --- r_associated #0: 10 --> lenvatinib n1=lactobacillus | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lamotrigine --- r_associated #0: 10 --> lenvatinib n1=lamotrigine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lidocaïne --- r_associated #0: 10 --> lenvatinib n1=lidocaïne | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lincomycine --- r_associated #0: 10 --> lenvatinib n1=lincomycine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lindane --- r_associated #0: 10 --> lenvatinib n1=lindane | n2=lenvatinib | rel=r_associated | relid=0 | w=10 liothyronine --- r_associated #0: 10 --> lenvatinib n1=liothyronine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 loratadine --- r_associated #0: 10 --> lenvatinib n1=loratadine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lorazépam --- r_associated #0: 10 --> lenvatinib n1=lorazépam | n2=lenvatinib | rel=r_associated | relid=0 | w=10 loxapine --- r_associated #0: 10 --> lenvatinib n1=loxapine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lubiprostone --- r_associated #0: 10 --> lenvatinib n1=lubiprostone | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lumacaftor --- r_associated #0: 10 --> lenvatinib n1=lumacaftor | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lurasidone --- r_associated #0: 10 --> lenvatinib n1=lurasidone | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lécithine --- r_associated #0: 10 --> lenvatinib n1=lécithine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lévamisole --- r_associated #0: 10 --> lenvatinib n1=lévamisole | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lévodopa --- r_associated #0: 10 --> lenvatinib n1=lévodopa | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lévofloxacine --- r_associated #0: 10 --> lenvatinib n1=lévofloxacine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 lévothyroxine --- r_associated #0: 10 --> lenvatinib n1=lévothyroxine | n2=lenvatinib | rel=r_associated | relid=0 | w=10 masitinib --- r_associated #0: 10 --> lenvatinib n1=masitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 mélisse --- r_associated #0: 10 --> lenvatinib n1=mélisse | n2=lenvatinib | rel=r_associated | relid=0 | w=10 mélisse officinale --- r_associated #0: 10 --> lenvatinib n1=mélisse officinale | n2=lenvatinib | rel=r_associated | relid=0 | w=10 quinolines --- r_associated #0: 10 --> lenvatinib n1=quinolines | n2=lenvatinib | rel=r_associated | relid=0 | w=10 ruxolitinib --- r_associated #0: 10 --> lenvatinib n1=ruxolitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 sunitinib --- r_associated #0: 10 --> lenvatinib n1=sunitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=10 L-dopa --- r_associated #0: 5 --> lenvatinib n1=L-dopa | n2=lenvatinib | rel=r_associated | relid=0 | w=5 cediranib --- r_associated #0: 5 --> lenvatinib n1=cediranib | n2=lenvatinib | rel=r_associated | relid=0 | w=5 crizotinib --- r_associated #0: 5 --> lenvatinib n1=crizotinib | n2=lenvatinib | rel=r_associated | relid=0 | w=5 famitinib --- r_associated #0: 5 --> lenvatinib n1=famitinib | n2=lenvatinib | rel=r_associated | relid=0 | w=5 génistéine --- r_associated #0: 5 --> lenvatinib n1=génistéine | n2=lenvatinib | rel=r_associated | relid=0 | w=5 lactose --- r_associated #0: 5 --> lenvatinib n1=lactose | n2=lenvatinib | rel=r_associated | relid=0 | w=5 pazopanib --- r_associated #0: 5 --> lenvatinib n1=pazopanib | n2=lenvatinib | rel=r_associated | relid=0 | w=5 ponatinib --- r_associated #0: 5 --> lenvatinib n1=ponatinib | n2=lenvatinib | rel=r_associated | relid=0 | w=5